AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Investigational Drug May Protect Body's White Cells; Drug Still Being Tested; White cells needed to beat infection, a result of radiation exposure.(HEALTH & MEDICINE)

Investor's Business Daily

| January 05, 2004 | COPYRIGHT 2004 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: PETER BENESH

On Dec. 21, the Bush administration put the country on orange alert. Intelligence indicated another terrorist attack on the U.S. could be imminent.

The government may have picked up signals of a chemical, biological or nuclear menace. It mobilized military and civilian detection teams.

Experts say a nuclear weapon would be worst, with the panic-raising combination of blast, fire and radiation.

One San Diego company claims it has the antidote to radiation's main threat to life.

Hollis-Eden Pharmaceuticals Inc. says its product, Neumune, may prevent white blood cells from dying when hit by radiation.

The body relies on white blood cells to fight infection. And infection, leading to death, is the common result of radiation exposure.

Related articles from newspapers, magazines, journals, and more
Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid...
Press release article from: PR Newswire September 16, 2009 700+ words
...PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. , a leader...2009. The letter states that Hollis-Eden is not in compliance with Nasdaq...with Nasdaq Marketplace Rules, Hollis-Eden has 180 days, or until March...
Hollis-Eden Pharmaceuticals and Edenland, Inc. Announce Settlement of...
Press release article from: PR Newswire January 21, 2000 700+ words
...Jan. 21 /PRNewswire/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq...includes the transfer of technology to Hollis-Eden for equity in the Company, and the funding by Hollis Eden of additional pre-clinical research...
Hollis-Eden Trims Work Force To Focus On Hormone Bids.
Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...Fallout from the rejection of Hollis-Eden Pharmaceuticals Inc.'s drug...Daniel Burgess, San Diego-based Hollis-Eden's chief operating officer and...privately held biotech firm, as Hollis-Eden moves ahead with work on its next...
Hollis-Eden Pharmaceuticals Announces Update On Collaboration with Aeson...
Press release article from: Business Wire October 25, 2002 700+ words
...BUSINESS WIRE)--Oct. 25, 2002 Hollis-Eden Pharmaceuticals, Inc. (NASDAQ...with Aeson Therapeutics, Inc. Hollis-Eden entered into a relationship with Aeson in October 2000, under which Hollis-Eden acquired equity in Aeson that...
Initial Acquisition Corp. Announces Definitive Merger Agreement With...
Press release article from: PR Newswire November 7, 1996 700+ words
...has signed a definitive Merger Agreement with Hollis-Eden Inc. (Hollis-Eden), a bio-pharmaceutical company engaged in...the treatment of viral and immune disorders. Hollis-Eden believes that its initial drug discovery, INACTIVIN...
Initial Acquisition Corp. announces definitive merger agreement with...
Press release article from: Business Wire November 11, 1996 700+ words
...has signed a definitive merger agreement with Hollis-Eden Inc. (Hollis-Eden), a biopharmaceutical company engaged in the...the treatment of viral and immune disorders. Hollis-Eden believes that its initial drug discovery, INACTIVIN...
Initial Acquisition Corp. Announces Definitive Merger Agreement with...
Press release article from: PR Newswire November 6, 1996 700+ words
...has signed a definitive Merger Agreement with Hollis-Eden Inc. (Hollis-Eden), a bio-pharmaceutical company engaged in...the treatment of viral and immune disorders. Hollis-Eden believes that its initial drug discovery, INACTIVIN...
BWR Begins Tracking Hollis-Eden Pharmaceuticals Inc.
Press release article from: M2 Presswire March 13, 2007 700+ words
...Biotech News: BWR Begins Tracking Hollis-Eden Pharmaceuticals Inc.(C)1994...had a hit with "Radioactive." Hollis-Eden Pharmaceuticals hopes to have...accident at a nuclear power plant). Hollis-Eden is getting help from the US Department...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA